Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall. This action has been classified as a Class I recall because of the risk of serious injury or patient death that could be associated with the use of this device. Over the last two years, Baxter has received serious injury reports and at least one patient death report associated with this issue.

“We stand ready to support our patients and the nephrology community as we develop and implement measures intended to reduce the occurrence of IIPV.”

Source Baxter International Inc.,

Posted in: Device / Technology News | Medical Procedure News

Tags: , , , , , , , , , , , , , , ,

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Baxter International Inc.. (2010, March 03). Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall. News-Medical. Retrieved on December 08, 2023 from https://www.news-medical.net/news/20100303/Baxter-Healthcares-IIPV-product-recall-of-HomeChoice-peritoneal-dialysis-cyclers-classified-as-Class-I-recall.aspx.

  • MLA

    Baxter International Inc.. "Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall". News-Medical. 08 December 2023. <https://www.news-medical.net/news/20100303/Baxter-Healthcares-IIPV-product-recall-of-HomeChoice-peritoneal-dialysis-cyclers-classified-as-Class-I-recall.aspx>.

  • Chicago

    Baxter International Inc.. "Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall". News-Medical. https://www.news-medical.net/news/20100303/Baxter-Healthcares-IIPV-product-recall-of-HomeChoice-peritoneal-dialysis-cyclers-classified-as-Class-I-recall.aspx. (accessed December 08, 2023).

  • Harvard

    Baxter International Inc.. 2010. Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall. News-Medical, viewed 08 December 2023, https://www.news-medical.net/news/20100303/Baxter-Healthcares-IIPV-product-recall-of-HomeChoice-peritoneal-dialysis-cyclers-classified-as-Class-I-recall.aspx.

Suggested Reading

Baxter plans to create two independent global healthcare companies
Baxter to establish new innovation and R&D center in Cambridge, MA
Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO
Crozer-Keystone Health System wins 2013 Foster G. McGaw Prize for Excellence in Community Service
Baxter submits BAX 855 NDA to Japan's MHLW for treatment of hemophilia A patients
Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A
Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial
Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »
You might also like...
Gilead to boost price of new hepatitis c drug